However, these approaches have not translated well to humans2–4, and it is uncertain whether synthetic Aβ peptides or APP transgenic mice can yield the type of neurotoxic Aβ assemblies that accumulate in the brains of humans with AD. Here, APP is linked to Alzheimer disease.